Invasive Meningococcal Disease, 2011–2020, and Impact of the COVID-19 Pandemic, England
Authors:
- Sathyavani SubbaraoSSSathyavani Subbarao
- Helen CampbellHCHelen Campbell
- Sonia RibeiroSRSonia Ribeiro
- Stephen A. ClarkSCStephen A. Clark
- Jay LucidarmeJLJay Lucidarme
- Mary RamsayMRMary Ramsay
- Ray BorrowRBRay Borrow
- Shamez LadhaniSLShamez Ladhani
Open Access
- 1 September 2021
- journal article
- letter
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 27 (9) , 2495-2497
Abstract
Invasive Meningococcal Disease, 2011–2020, and Impact of the COVID-19 Pandemic, EnglandKeywords
This publication has 8 references indexed in Scilit:
- Impact of COVID-19 pandemic and the lockdown on invasive meningococcal diseaseBMC Research Notes, 2020
- Vaccination of Infants with Meningococcal Group B Vaccine (4CMenB) in EnglandNew England Journal of Medicine, 2020
- Emergency Meningococcal ACWY Vaccination Program for Teenagers to Control Group W Meningococcal Disease, England, 2015–2016Emerging Infectious Diseases, 2017
- Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort studyThe Lancet, 2016
- Invasive meningococcal disease in England: assessing disease burden through linkage of multiple national data sourcesBMC Infectious Diseases, 2015
- Invasive meningococcal disease in England and Wales: Implications for the introduction of new vaccinesVaccine, 2012
- Global epidemiology of meningococcal diseaseVaccine, 2009
- Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysisBMJ, 2003